These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 11391850

  • 1. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C.
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [Abstract] [Full Text] [Related]

  • 2. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H, Nagatomo A, Kunitoh H, Kunikane H, Watanabe K.
    Cancer Chemother Pharmacol; 1998 May; 42(4):307-12. PubMed ID: 9744776
    [Abstract] [Full Text] [Related]

  • 3. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I.
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin.
    van Warmerdam LJ, Rodenhuis S, ten Bokkel Huinink WW, Maes RA, Beijnen JH.
    Cancer Chemother Pharmacol; 1996 Nov; 37(3):266-70. PubMed ID: 8529288
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K, Lipp HP, Beijnen JH, Bokemeyer C, Hartmann JT.
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
    [Abstract] [Full Text] [Related]

  • 8. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ, Poole SG, Rischin D, Webster LK.
    Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
    [Abstract] [Full Text] [Related]

  • 9. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C, de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH.
    Clin Cancer Res; 2006 Nov 01; 12(21):6502-8. PubMed ID: 17085665
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML, Hsieh T, Hamata L, Levin A, Swenerton K, Djurdjev O, Vu T, Hu F, Conklin J, Malfair Taylor SC.
    Gynecol Oncol; 2006 Dec 01; 103(3):1063-9. PubMed ID: 16875719
    [Abstract] [Full Text] [Related]

  • 11. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
    Morrow A, Garland C, Yang F, De Luna M, Herrington JD.
    J Oncol Pharm Pract; 2019 Oct 01; 25(7):1651-1657. PubMed ID: 30336729
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level.
    Ando M, Minami H, Ando Y, Saka H, Sakai S, Yamamoto M, Sasaki Y, Shimokata K, Hasegawa Y.
    Clin Cancer Res; 2000 Dec 01; 6(12):4733-8. PubMed ID: 11156227
    [Abstract] [Full Text] [Related]

  • 19. [Study of the predictive method of 24-hour creatinine clearance in calculating the appropriate dosage of Carboplatin].
    Hirai R, Shimano Y, Isobe K, Koshikawa I, Ohno K, Kishino S, Homma S, Suga N.
    Yakugaku Zasshi; 2008 Aug 01; 128(8):1209-14. PubMed ID: 18670187
    [Abstract] [Full Text] [Related]

  • 20. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?
    MacAulay J, Thompson K, Kiberd BA, Barnes DC, Peltekian KM.
    Can J Gastroenterol; 2006 Aug 01; 20(8):521-6. PubMed ID: 16955148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.